Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definition
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Increasing prevalence of postpartum depression
3.2.1.2    Advancements in drug development
3.2.1.3    Growing awareness and focus on women’s health
3.2.2    Industry pitfalls and challenges
3.2.2.1    Safety concerns due to associated side effects
3.2.2.2    High cost of postpartum depression drugs
3.3    Growth potential analysis
3.4    Future trends
3.5    Regulatory landscape
3.6    Pipeline analysis
3.7    Porter’s analysis
3.8    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company matrix analysis
4.3    Competitive analysis of major market players
4.4    Competitive positioning matrix
4.5    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Postpartum anxiety
5.3    Postpartum blues
5.4    Postpartum post-traumatic stress disorder (PTSD)
5.5    Postpartum obsessive-compulsive disorder (OCD)
5.6    Postpartum panic disorder
5.7    Postpartum psychosis
Chapter 6   Market Estimates and Forecast, By Treatment, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Pharmacotherapy
6.2.1    Selective serotonin reuptake inhibitors (SSRIs)
6.2.2    Serotonin norepinephrine reuptake inhibitors (SNRIs)
6.2.3    Tricyclic antidepressants (TCA)
6.2.4    Other pharmacotherapies
6.3    Hormone therapy
6.4    Other treatments
Chapter 7   Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Oral
7.3    Parenteral
7.4    Other routes of administration
Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Hospital pharmacies
8.3    Retail pharmacies
8.4    Online pharmacies
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Italy
9.3.5    Spain
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    Bausch Health Companies
10.2    Biogen
10.3    Cipla
10.4    Eli Lilly and Company
10.5    GSK
10.6    Merck
10.7    Novartis
10.8    Pfizer
10.9    Sage Therapeutics
10.10    Teva Pharmaceutical Industries